01.06.2014
- UK pharmaceutical producer GlaxoSmithKline has invited private equity firms to consider making offers for a range of its older drugs, news agencies report, citing people familiar...
23.04.2014
- Novartis and GlaxoSmithKline have announced an asset swap worth more than $20 billion, with an eye to bolstering their best businesses and exiting weaker ones. The swap, which...
25.09.2013
- Germany's Merck KGaA said it would start a new study testing its experimental lung cancer vaccine Stimuvax, which fell through in a previous late-stage trial. Merck said it would...
25.07.2013
- Swiss drug maker Novartis suffered a fresh blow to the turnaround prospects of its loss-making vaccines division as a key committee advised against including its meningitis B...
28.06.2013
- Merck Serono, the biopharmaceutical division of Germany-based Merck KGaA, has created a dedicated immune-oncology innovation platform integrating research, early development and...
29.05.2013
- GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for €250 million ($321 million) - the latest bolt-on biotech buy...
23.05.2013
- Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the...
13.04.2013
- Even as U.S. officials this week awaited the arrival of a sample of the new bird flu virus from China - typically the first step in making a flu vaccine - government-backed...
